Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

DOI Full Paper Access

438

Citations

24

References

2022

Year

Zhihao Lü, Junye Wang, Yongqian Shu, Lianke Liu, Li Ren Kong, Lei Yang, Buhai Wang, Guogui Sun, Yinghua Ji, Guochun Cao,

Abstract

ClinicalTrials.gov NCT03748134.

References

	Year	Citations

Page 1